Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.

Brian Green, P.R. Flatt, K. Lavery, N. Irwin, F.P.M. O'Harte, Patrick Harriott, Brett Greer, C.J. Bailey

Research output: Contribution to journalArticle

44 Citations (Scopus)
Original languageEnglish
Pages (from-to)914-921
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume318(2)
Issue number2
DOIs
Publication statusPublished - Apr 2006

Cite this

@article{c261aa8360724ab09aa69891420fcbc8,
title = "Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.",
author = "Brian Green and P.R. Flatt and K. Lavery and N. Irwin and F.P.M. O'Harte and Patrick Harriott and Brett Greer and C.J. Bailey",
year = "2006",
month = "4",
doi = "10.1124/jpet.105.097824",
language = "English",
volume = "318(2)",
pages = "914--921",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

TY - JOUR

T1 - Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.

AU - Green, Brian

AU - Flatt, P.R.

AU - Lavery, K.

AU - Irwin, N.

AU - O'Harte, F.P.M.

AU - Harriott, Patrick

AU - Greer, Brett

AU - Bailey, C.J.

PY - 2006/4

Y1 - 2006/4

UR - http://www.scopus.com/inward/record.url?scp=33745937115&partnerID=8YFLogxK

U2 - 10.1124/jpet.105.097824

DO - 10.1124/jpet.105.097824

M3 - Article

C2 - 16648370

VL - 318(2)

SP - 914

EP - 921

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 2

ER -